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Pain and analgesia in rabbits: a review.  
Abstract  
Objective To provide an overview of pain and analgesia in rabbits with the aim of developing 
a more accurate understanding of these topics. To illustrate and discuss the areas that have 
advanced in recent years and those that still require further research.  
Databases used Three key subject resources were used: Web of Science, Medline and CAB 
Abstracts. Search terms including rabbits, lagomorphs, laboratory animals, pet, pain, surgical 
procedures, ovariohysterectomy, orchiectomy, castration, analgesia, opioids, and non-
steroidal-anti-inflammatory drugs were included. References from books and articles relevant 
to the topics were also included.  
Conclusions Rabbit medicine has improved over the last 20 years, but the literature suggests 
that pain management in this species is still inadequate and veterinary professionals believe 
their knowledge of pain and analgesia in this species is limited. Assessment and quantification 
of pain in rabbits can be challenging in a clinical environment not only because as prey species 
rabbits tend to hide signs of pain but also because there are no validated methods to assess pain 
except the Rabbit Grimace Scale (RbtGS) which is based on only one rabbit breed.  
It is the current consensus that peri-operative multimodal analgesia is best practice. However, 
it is not widely used in rabbits. In rabbits, analgesia protocols and dosages reported in the 
literature are often poorly researched and do not result in complete pain amelioration with the 
return of normal behaviour of the rabbit. The present literature on rabbit pain and analgesia 
presents gaps either due to unexplored areas or insufficient findings. Further research should 
focus on these areas with the aim of improving the welfare of rabbits within a veterinary clinic.  
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Introduction 
In the United Kingdom (UK), 68% of the pet rabbit population is registered with a veterinary 
clinic, and it is estimated that circa 600,000 rabbits are neutered every year (PAW-Report 
2017). Despite the high number of rabbits undergoing surgical procedures, anaesthesia and 
analgesia protocols for rabbits are still limited compared to those for cats and dogs (Johnston 
2005; Keown et al. 2011). Moreover, rabbit mortality rate (1.39%) is 6 - 8 times higher than 
cats (0.24%) and dogs (0.17%) respectively (Brodbelt 2009). Uncontrolled and poorly 
managed perioperative pain, prolonged recovery time and postoperative gastrointestinal ileus 
are well-recognised causes of mortality in pet rabbits (Longley 2008; Brodbelt 2009; Wenger 
2012).   
In 1999, a survey on perioperative analgesia in cats and dogs showed that analgesia was not 
always administered postoperatively, and only a small number of animals received any form 
of analgesia during routine procedures such as neutering (cats: ovariohysterectomy 26%, 
castration 16%; dogs: ovariohysterectomy 53%, castration 32 %) (Capner et al. 1999).  Similar 
results were shown in a study of small mammals where only 22% of animals such as rabbits, 
ferrets, guinea pigs and hamsters undergoing surgical procedures received analgesia (Lascelles 
et al. 1999).  
In recent years, analgesia administration in companion animals such as cats and dogs has 
increased, and in 2013, 98% of surveyed UK veterinary surgeons reported administering some 
form of analgesia for routine procedures (Hunt et al. 2015). It is unknown if similar trends have 
occurred for small mammals such as rabbits. At present, it appears that veterinarians treating 
rabbits (including those kept in laboratories) are unfamiliar and unsure of available drugs, 
dosage ranges and the effects of the drugs (Leach et al. 2009; DiVincenti et al. 2016).  A recent 
study showed that there was a poor compliance rate amongst New Zealand veterinarians in 
using analgesia in small mammals such as rabbits and guinea pigs (Keown et al. 2011).  More 
  
than 60% of the respondents felt their knowledge of pain recognition, and analgesia in these 
two species was inadequate (Keown et al. 2011). This percentage is nearly twice the percentage 
of veterinarians (30-42%) that doubt their knowledge in recognising pain in cats and dogs  
(Weber et al. 2012; Beswick et al. 2016).    
Assessment and quantification of pain are considered challenging due to differences in the 
expression of pain across individuals and species and a lack of a ‘gold standard’ method to 
assess pain. Moreover, the rabbit as a prey species is evolutionally predisposed to mask signs 
of pain, making this task even more difficult.   
This review will explore what can cause pain in rabbits, concentrating in particular upon the 
veterinary environment, will give an introduction to how pain can be assessed in rabbits and 
finally it will describe what is currently available regarding protocols and drugs to ameliorate 
pain in rabbits while at the clinic.  
Three key subject resources were used: Web of Science, Medline and CAB Abstracts. Search 
terms including rabbits, lagomorphs, laboratory animals, pet, pain, surgical procedures, 
ovariohysterectomy, orchiectomy, castration, analgesia, opioids, and non-steroidal-anti-
inflammatory drugs were included. References from books and articles relevant to the topics 
were also included. The research will consider references on both laboratory and pet rabbits.    
 
Painful procedures and conditions in rabbits  
Pain has been defined by the International Association for the Study of Pain as ‘An unpleasant 
sensory and emotional experience associated with actual or potential tissue damage’ 
(https://www.iasp-pain.org/terminology?navItemNumber=576#Pain). Three studies have 
attempted to classify veterinary conditions that could lead to pain in rabbits.  One study on pet 
rabbits reported common conditions such as gastrointestinal diseases, fight wounds, neutering 
and urinary problems to be painful (Rooney et al. 2014). This study had an expert panel rate 
  
levels of suffering associated with each condition but not specifically the severity of pain.  A 
second study instead focused on surgical procedures performed on pet rabbits and the intensity 
of pain (Keown et al. 2011).  Orthopaedic procedures were scored as the most painful 
procedures, followed by ovariohysterectomy (OVH), castration and surgical treatment of 
abscesses. Tumour surgical removal and dental treatment were described as less painful 
procedures (Keown et al. 2011).  Similar findings were found in a study on laboratory rabbits; 
orchiectomy and caesarean section were considered causing mild to moderate pain while major 
laparotomy and organ incision were suggested to cause moderate to severe pain (Kohn et al. 
2007). These studies overall agree with the findings of those reported in other species where, 
for example, OVH is considered a more painful procedure than orchiectomy reflecting the 
different complexities of the two surgical procedures. 
 
Pain assessment   
The experience of pain is multi-dimensional involving physiological and behavioural changes. 
These changes can be identified in rabbits experiencing pain and can be used as assessment 
tools (Kohn et al. 2007). However, pain recognition can be affected by factors such as the 
individual, age, the subjectivity of the observer etc.  Moreover, physiological parameters have 
a limited function as they can also be altered by positive arousal and concurrent problems such 
as infections and stress, masking the changes due to pain. In rabbits, an increase in heart and 
respiratory rate is often seen during handling (Wenger 2012; Varga 2014) while body 
temperature does not seem to be altered by pain (Cooper et al. 2009). However, a decrease in 
body weight was a common finding in many studies on rabbit pain and analgesia (Cooper et 
al. 2009; Leach et al. 2009; Weaver et al. 2010; Goldschlager et al. 2013). It was deduced that 
this was due to a reduced appetite.  Details of research studies reporting pain-related 
physiological changes in rabbits are summarised in Table 1.   
  
Behavioural changes are considered a more valuable and reliable method to assess pain in 
rabbits and a return to what is considered normal behaviour for this species is regarded as a 
reliable indicator that pain is no longer present or that the analgesic treatment is effective 
(Mayer 2007).   In a study of 20 female New Zealand White (NZW) rabbits following OVH, it 
was found that appetite, faecal output and travelling distance decreased postoperatively in all 
animals (Weaver et al. 2010).  Another study of seven male NZW rabbits following abdominal 
surgery also noticed a reduction of activity, exploring and appetite postoperatively (Farnworth 
et al. 2011). The authors also noticed an increase of grooming of the surgical wound area and 
body flinching (Farnworth et al. 2011). Details of research studies reporting pain-related 
behaviours of rabbits found in the literature are summarised in Table 1.  
 
Pain scales 
Pain scales can be used to carry out a more structured pain evaluation of the animal and allow 
the intensity of the pain to be quantified: the higher the score, the higher the level of pain that 
the animal is suffering. This can help the clinician to determine if successful pain management 
has been achieved or if further analgesia is needed to prevent the animal from suffering.  
The first known attempt to quantify pain in laboratory animals such as cats and dogs but also 
rabbits and rats was made in 1985 (Morton & Griffiths 1985). They used several variables such 
as body weight, animal appearance, physiological parameters, unprovoked behaviour and 
behavioural responses to external stimuli to achieve an overall score using a scale from 0 
(normal) to 3-4 (severe). To date, there have not been follow-up studies to further develop a 
composite pain scale for rabbits. 
Grimace scales are now popular and use changes in facial expression to quantify pain.  They 
have been developed and validated in several species (Sotocinal et al. 2011; Leach et al. 2012; 
Dalla Costa et al. 2014; Hageri et al. 2017) and recently also in rabbits as well (Keating et al. 
  
2012). The facial expression of rabbits was evaluated and scored by observers while the rabbits’ 
ears were tattooed with or without the use of local anaesthesia. It was found that some facial 
features changed depending on the level of the pain. The scale varies from ‘Not present’ (0) to 
‘Obviously present’ (2) for each action unit and assesses facial changes such as orbital 
tightening, cheek flattening, nose shape, whisker position and ear position.  
Despite the fact that several pain-scoring systems are now available for veterinarians, pain 
assessment tools are still rarely used. In two recent survey on cats and dogs from UK and 
Australia, only 17% and 20% of the respondents respectively reported using pain scales (Weber 
et al. 2012; Hunt et al. 2015). In a review on pain management in laboratory pigs, only one 
article (1/233) described the use of a pain scoring system (Bradbury et al. 2016). Similarly, 
little use of pain scales is reported in rabbits (Grint 2013). 
 
Pain amelioration 
In a clinical setting, perioperative analgesia is of great importance in order not only to reduce 
negative effects and complications following a surgical procedure but also to reduce the risks 
under anaesthesia (Bonnet & Marret 2005). The right analgesic protocol aims to minimise pain 
and allows the animal to exhibit more normal behaviour, starting the recovery more quickly. 
Pain can be controlled by both pharmaceutical and non-pharmaceutical approaches. A non-
pharmaceutical approach is defined as methods that do not employ drugs, as part of a 
multimodal approach to pain management (Corti 2014). Techniques such as cold and heat 
therapy, acupuncture (Parmen et al. 2015) and low-level-laser therapy (LLLT) are anecdotally 
used in rabbits(Cho et al. 2004). However, too few references have been found in the literature 
to understand if they can be beneficial in rabbits and they will not be discussed further in this 
review. 
  
Pain can be prevented and reduced in many ways, and expert opinion is that a multimodal 
approach, a combination of two or more different types of analgesic drugs administered 
together, should be considered (Bonnet & Marret 2005). In pet rabbit medicine, multimodal 
analgesia is advised (Longley 2008; Wenger 2012; Goldschlager et al. 2013). However in a 
review of 128 papers on the analgesic administration to laboratory rabbits a decade ago, only 
48% of the studies reported systemic analgesia agents, and none reported the use of a 
multimodal approach (Coulter et al. 2011). Buprenorphine alone was used in 60-70% of the 
studies while non-steroidal anti-inflammatory drugs (NSAIDs) were used only in 20-21%. The 
authors, however, noticed an increased use of systemic analgesia from 16% to 48% over a 10-
year period (Coulter et al. 2011). Further current research is necessary in this field in this 
species. 
 
Opioids 
Opioids are a category of versatile and efficacious drugs that are used to inhibit pain and can 
be dosed to effect. They are largely used in companion animals for their analgesic and sedative 
properties as part of the anaesthesia premedication protocol and perioperative analgesia. The 
side effects of opioid drugs are only seen with overdose; common side effects in rabbits include 
respiratory depression, bradycardia, hypothermia, drowsiness (Wenger 2012; Varga 2014), 
decreased arterial blood pressure, increased arterial carbon dioxide and a drop in arterial 
oxygen tension (Goldschlager et al. 2013). Opioids also have the potential to reduce 
gastrointestinal motility. However, this does not seem to have clinical relevance in rabbits 
(Cooper et al. 2009; Goldschlager et al. 2013; Deflers et al. 2018). 
For rabbits, the main opioids used and reported in the literature are partial µ agonists such as 
buprenorphine, agonist-antagonists such as butorphanol and full µ agonists such as fentanyl 
(Coulter et al. 2009; Wenger 2012; Varga 2014). Morphine, methadone and oxymorphone have 
  
also been used to treat severe acute pain (Barter 2011; Meredith 2015), but little is known about 
their clinical relevance and effects in rabbits.  
Buprenorphine is a partial agonist at the mu receptor and is the most commonly used analgesic 
drug in rabbits (Coulter et al. 2011). It is administered at a dose of 0.01-0.05 mg kg -1 with 
duration of action of 6-10 hours (Meredith 2015). It can be administered via the intravenous 
(IV), intramuscular (IM), subcutaneous (SC) and trans-mucosal (OTM) route (Wenger 2012). 
Intranasal bioavailability of buprenorphine in rabbits has also been assessed with an absorption 
rate of 10 minutes (mean TMAX) (Lindhardt et al. 2001). The SC and OTM routes are considered 
less reliable routes with poor absorption in rabbits (Freijs & Kannin 2016). In a study on 24 
male NZW rabbits during a three day post-operative period, a dosage of 0.02 mg kg-1 
buprenorphine every 12 hours given SC resulted in four animals showing moderate to severe 
pain by the time they were due the next dose (DiVincenti et al. 2016).  Another study that tested 
post-operative analgesia for orthopaedic surgeries in 18 male NZW rabbits suggested that a 
dose of 0.02-0.05 mg kg -1 SC did not provide adequate analgesia (Hedenqvist et al. 2016). The 
adjunct of carprofen at 5 mg kg -1 also did not help to relieve the pain in these rabbits 
(Hedenqvist et al. 2016). However the combination of buprenorphine (0.01 mg kg -1) and 
meloxicam (0.1 mg kg -1) together given SC seemed to mitigate pain in 39 male NZW rabbits 
during a post-operative period of three days after receiving a vascular cut-down procedure of 
the femoral artery (Goldschlager et al. 2013). These studies suggest that although a multimodal 
approach is advisable, the choice of NSAID might also need to be taken into consideration.  
Moreover, the efficacy of the dose rate related to the severity of the procedure should also be 
further researched.  
Butorphanol is a mu-antagonist and k-agonist opioid suitable for the treatment of mild to 
moderate pain. It is advised at a dose of 0.1-0.5 mg kg -1 (Meredith 2015) and has a duration 
of action of around 2-4 hours in rabbits (Goldschlager et al. 2013). It can be administered via 
  
the IM and IV route, but it has a longer half-life when given SC (3.2 hours) than IV (1.6 hours) 
(Varga 2014). Fentanyl is a full mu-agonist and is administered in rabbits in combination with 
fluanisone, a butyrophenone derivate (Hypnorm) at a combined dose of 0.2-0.3 mL kg-1 
(Meredith 2015). Hypnorm is licensed for the sedation and anaesthesia in rabbits in the UK, 
and it can be antagonised by butorphanol and buprenorphine. Transdermal administration of 
fentanyl in rabbits has also been reported providing analgesia for three days (Foley et al. 2001; 
Wenger 2012). Another opioid commonly used in rabbits is tramadol. It has low activity at the 
mu opioid receptor and inhibits noradrenaline and serotonin reuptake  (Souza et al. 2008). It is 
commonly used to treat mild acute and chronic pain due to osteoarthritis and neoplasia 
(Meredith 2015). In companion animals like cats and dogs, tramadol is administered at a dosage 
of 1-4 mg kg -1 (KuKanich 2013) while in rabbits, it is administered orally (PO) at a dosage of 
3-10 mg kg -1 (Johnston 2005; Meredith 2015). However, a recent study showed that a dose of 
11 mg kg -1 did not reach the human therapeutic plasma concentration and a higher dose might 
be necessary to provide analgesia in this species (Souza et al. 2008). In a study on six female 
NZW rabbits, 4.4 mg kg -1 tramadol administered IV while under anaesthesia using isoflurane 
vaporised in 100% oxygen caused a decrease in heart rate and arterial blood pressure with a 
minimal change in the minimum alveolar concentration of isoflurane (Egger et al. 2009). 
 
Non-steroidal anti-inflammatory drugs  
Non-steroidal anti-inflammatory drugs have antipyretic, anti-inflammatory and analgesic 
activity (Mathews et al. 2014). They are contraindicated in rabbits with hepatic and renal 
diseases, gastrointestinal ulcerations and conditions with reduced organ perfusion (Johnston 
2005). 
Commonly reported NSAIDs used in rabbits are carprofen and meloxicam (Barter 2011).  
Flunixin meglumine and ketoprofen have also been reported to be used in rabbits (Coulter et 
  
al. 2009), but little is known about their efficacy in this species. Use of acetylsalicylic acid and 
paracetamol has also been reported in rabbits (Varga 2014), but with poor analgesic and anti-
inflammatory properties when compared to the other NSAIDs and they are currently rarely 
administered.  
Carprofen is an NSAID with weak cyclo-oxygenase inhibitor properties, and it is used to treat 
mild to moderate acute and chronic pain. It can be administrated in rabbits IV, SC and PO at a 
dose of 2-4 mg kg -1 (Carpenter 2005; Hawkins 2002). However, no known pharmacokinetic 
studies have been carried out in rabbits, and the dose rates are untested (Varga 2014).  A recent 
study showed that 5 mg kg -1 of carprofen administered to rabbits postoperatively in 
conjunction with buprenorphine did not reduce the grimace scale pain score when compared to 
the control group (buprenorphine only) (Hedenqvist et al. 2016). 
Meloxicam is a well used and tested NSAIDs in companion animals including rabbits (Turner 
et al. 2006; Leach et al. 2009; Goldschlager et al. 2013). It can be administered SC, IM and 
PO. In cats and dogs, it is administered at a loading dose of 0.3 and 0.2 mg kg -1 respectively 
(Ramsey 2014) while in laboratory animals such as rats and mice a dosage of 1-2 mg kg -1  is 
considered necessary to achieve an adequate analgesic effect (Carpenter 2005). In rabbits, the 
administration is currently advised at a dosage of 0.6 mg kg -1 up to 1 mg kg -1 (Meredith 2015). 
A study on ten female NZW rabbits reported that rabbits could be treated with meloxicam at a 
dose of either 0.3 mg kg -1 or 1.5 mg kg -1 PO given once a day for five days (Turner et al. 
2006).  These results were later confirmed and the dosage of 0.2-0.3 mg kg -1 once a day was 
tolerated by eight female NZW rabbits over a period of ten days (Carpenter et al. 2009).  In 
2013, Fredholm et al. also carried out a study to assess the pharmacokinetics of meloxicam 
administered PO. It was tested on six  NZW rabbits at a dosage of 1 mg kg -1 once a day over 
five days and found to be well-tolerated (Fredholm et al. 2013). These results were later 
confirmed by Delk et al. (2014), who demonstrated that the administration of 1 mg kg -1 of 
  
meloxicam once a day for 29 days was safe in this species, with no obvious side effects detected 
(Delk et al. 2014). These findings may also suggest that it may be a suitable regimen for the 
treatment of chronic pain in rabbits. Although, additional trials are required.  
A study on 30 Female Dutch belted rabbits undergoing OVH showed that meloxicam at a 
dosage of 0.2 mg kg -1  given  SC once a day for two days was comparable to a group receiving  
buprenorphine (0.03 mg kg -1 IM q 12 hours).(Cooper et al. 2009). However, all animals 
showed decreased food intake, faecal output and weight suggesting that perhaps all animals 
suffered a degree of discomfort. In 28 female NZW rabbits, a dose of 1 mg kg -1 on the day of 
the surgical procedure followed by 0.5 mg kg -1 during the following two days, instead seemed 
to induce some degree of postoperative analgesia when compared to the control group and the 
two treatment groups at lower dosages of meloxicam (Leach et al. 2009).  In the study on 39 
male NZW rabbits receiving a vascular cut-down procedure, a combination of buprenorphine 
at 0.01 mg kg -1  and meloxicam at 0.1 mg kg -1 once a day  for three days seemed to be more 
beneficial  compared to  meloxicam given solely subcutaneously at 0.2 mg kg -1 once daily 
(Goldschlager et al. 2013). These results were based on body weight, food intake and faecal 
and urinary output.  These studies in conjunction with the pharmacokinetic trials suggest that 
postoperative analgesia in rabbits is yet not fully understood and pain is not adequately treated 
in this species.   
 
Local anaesthetics  
Local anaesthetics are a group of drugs that are sodium channel blockers, and they block the 
transmission of painful stimulation to the CNS (Johnston 2005).  In rabbits, local side effects 
are associated with potential neurotoxicity during the tissue infiltration (Gozil et al. 2002).  In 
humans and animals, systemic side effects are associated with neurological and cardiovascular 
signs and systemic hypotension due to accidental intravascular injection (Adam et al. 2011).  
  
Common local anaesthetic drugs used in rabbits are EMLA cream (a eutectic mixture of 2.5% 
prilocaine and 2.5% lidocaine), and lidocaine and bupivacaine injectable solutions (Wenger 
2012). In rabbits, EMLA cream is used for procedures such as ear tattooing (Keating et al. 
2012) and placement of intravenous catheters (Varga 2014). Lidocaine (2-4 mg kg-1) and 
bupivacaine (0.5-1 mg kg-1) are used for local infiltration and, for nerve blocks for dental 
extraction, intra-testicular administration during castration and epidural analgesia (Wenger 
2012; Johnson-Delaney & Harcourt-Brown 2013; Varga 2014). A recent study on laboratory 
rabbits demonstrated that application of 1 mm thick layer of EMLA cream applied to both inner 
and outer surface of the pinna 20 minutes before ear tattooing reduced struggling during 
handling and reduced physiological and behavioural changes associated with pain (Keating et 
al. 2012). In a veterinary clinic setting, EMLA cream is reported as an effective local 
anaesthetic to prevent the rabbit from head shaking during venepuncture and insertion of IV 
catheters (Longley 2008; Varga 2014). Wound infiltration and nerve blocking during dental 
procedures with lidocaine and bupivacaine reduce the risks of self-trauma and anorexia in 
rabbits (Varga 2014).  A study on 39 male NZW rabbits showed that a single dose of  0.5% 
bupivacaine given postoperatively at the site of the surgical skin incision gave similar results 
to the administration of meloxicam alone or buprenorphine alone (Goldschlager et al. 2013). 
However, it was also noticed that the rabbits in these three groups (bupivacaine, meloxicam 
and buprenorphine) all had an increase of faecal corticosterone metabolites and a reduction of 
body weight during the first seven days postoperatively, suggesting that the rabbits experienced 
stress or pain despite the analgesic treatments (Goldschlager et al. 2013). 
In two recent surveys, in Australia and the UK,  investigating the veterinarians’ perception of 
pain in cats and dogs it was found that none (Weber et al. 2012) or few (Hunt et al. 2015) of 
the respondents used local anaesthetic drugs with members of the Association of Veterinary 
Anaesthetists being more likely to use local anaesthetic drugs (Hunt et al. 2015).  This would 
  
suggest that more research and education might be necessary to incorporate local anaesthetics 
within an analgesic protocol.  
 
Discussion 
This review provides an overview of the relevant literature published over the last 20 years on 
rabbit pain assessment and quantification and the efficacy of analgesic drugs in this species.  
The study populations in many of the scientific papers comprise laboratory rabbits rather than 
pet rabbits. This does not come as a surprise as rabbits are widely used as experimental models 
in both human and animal research. However, pet and laboratory rabbit populations can be 
very different from a demographic and management point of view. While the pet rabbit 
population presents several breeds with different body sizes and types, more akin to the cat and 
dog population, the laboratory rabbit population is often limited to fewer breeds such as the 
NZW, and Dutched Belted rabbits, kept in standardised conditions.  Laboratory rabbits are 
young and healthy, and therefore the research findings rarely take into consideration the 
differences in age and potential concurrent health problems, that are more likely to be found in 
pet rabbits. Moreover, although pain relief must be provided to laboratory rabbits undergoing 
painful procedures (https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=celex%3A32010L0063), the choice of the analgesic drug may be 
dictated also by the need of preventing side effects and complications that could interfere with 
the study’s findings rather than the complete return to the animal’s normal behaviour (Carbone 
& Austin 2016; Hedenqvist et al. 2016). For these reasons, studies on analgesia reported in 
laboratory rabbits might not be suitable for pet rabbits and the types of surgical procedures that 
are commonly performed in veterinary clinics. However, during this review, it was noticed that 
in the last few years, more studies have been designed with the pet rabbit in mind or using a 
  
pet rabbit population. This suggests an increased interest in these pets and the 
acknowledgement of their specific needs.  
During the review of the literature published on pain assessment, three studies were found on 
laboratory rabbits (Leach et al. 2009; Weaver et al. 2010; Farnworth et al. 2011) and none on 
pet rabbits.  All three studies aimed to identify the behavioural response to pain to optimise 
postoperative analgesia. Ethograms of rabbit behaviours observed during the studies were 
developed. One study (Leach et al. 2009) found that behaviours such as twitch, wince and 
staggering grouped as “Inactive pain behaviour” were the most indicative indicators of pain. 
Weaver et al. (2010) instead reported that a reduction in activity was a better indicator of pain 
while Farnworth et al. (2011) concluded that a decline in those behaviours that are commonly 
expressed such as eating and exploring, may be a more effective way of assessing postoperative 
pain.  Although the three studies do not agree, they all describe potential behaviours that rabbits 
may express while experiencing pain. It is the general consensus that the use of behavioural 
indicators can be very subjective, and that it relies not only on the knowledge of the species 
and the individual studied but also on the experience of the observer (Kohn et al. 2007).  
Recently the Rabbit Grimace Scale (RbtGS) has been validated as an effective method to assess 
acute pain in laboratory rabbits. The main advantage of the RbtGS is that is based on only five 
action units that makes it more accurate and less time-consuming than assessing several 
behavioural indicators.  The main limitation is that it is based on only one breed of rabbit: New 
Zealand White. Although, in a laboratory context this would not be a problem, in a veterinary 
clinic it would limit its use as many rabbit breeds with different types of ears and face shapes 
are generally presented. A way to bypass these limitations could be to perform a ‘preoperative’ 
pain assessment once the rabbit is admitted to the hospital. This would emphasise those 
behaviours and anatomical features specific to the individual rabbit and that might not 
necessarily change due to pain. However, a more objective approach such as a 
  
multidimensional composite pain scale specific for this species and validated for several breeds 
of rabbits would overall improve the pain recognition and the use of analgesia.  The 
characteristics of a composite scale are that it should be reliable, repetitive and easy to use 
(Mathews et al. 2014). Moreover, it should quantify pain allowing a more accurate rescue 
analgesia intervention. A composite scale for laboratory animals, including rabbits, was 
developed in 1985 (Morton & Griffiths 1985). This scale was then used as guideline for the 
development of validated composite scales in other animals but not in rabbits leaving a gap 
regarding pain assessment in this species.  
The management of pain in rabbits is difficult for several reasons. Without a validated pain 
assessment tool, it is challenging to properly assess if an analgesic drug is effective. Moreover, 
drugs used to treat rabbits in veterinary clinics are broadly untested with only few papers 
published. Amongst NSAIDs, meloxicam is one of the most commonly used drugs in rabbits, 
and several published studies have been found during this literature review.  Four papers were 
found on the pharmacokinetics alone. Two studies concluded that a dosage 3 to 8 times higher 
than 0.2 – 0.3 mg kg-1 may be required in rabbits (Turner et al. 2006; Carpenter et al. 2009). 
Two later studies confirmed that 1 mg kg-1 was necessary to achieve a clinically effective 
concentration  (Fredholm et al. 2013; Delk et al. 2014). Leach et al. (2009) clinically assessed 
meloxicam at dosages of  0.2, 0.6  and 1 mg kg-1  followed 24 hours later respectively by 0.1, 
0.3 and 0.5 mg kg-1 in 28 NZW rabbits undergoing OVH. The authors concluded that these 
three dosages were still not adequate to completely treat pain in rabbits undergoing OHV but 
that the two higher dosages (0.6 and 1 mg kg -1) were more effective in controlling pain than 
the lower one at 0.2 mg kg -1.   This was later confirmed by Goldschlarger et al. (2013) who 
demonstrated that 0.2 mg kg -1 did not have any analgesic benefits. That study also assessed a 
multimodal analgesic approach and demonstrated that a combination of buprenorphine at 0.01 
mg kg-1 and meloxicam at 0.1 mg kg -1 administered SC daily was more effective than 
  
meloxicam or buprenorphine administered alone. Although it might be difficult to compare 
these studies as the methodologies are often significantly different, they all  demonstarted that 
meloxicam should be given in rabbits at higher dosages than in cats and dogs. The study by 
Goldschlarher et al. (2013) also demonstrated the benificial effects of a multimodal analgesic 
approach in rabbits. Multimodal analgesia in rabbits is recommended in many books, articles 
and conference proceedings on rabbit pain and analgesia. However little is reported on effective 
combinations with the return of what would be considered a normal behaviour in this species. 
Multimodal analgesia is still a largely underresearched field in rabbits.   
 
Conclusions 
The literature reported presents gaps due to either unexplored areas or insufficient findings. 
This review suggests there have been advances in research in order to better understand pain 
assessment and management in pet rabbits. Assessment and quantification of pain in this 
species can be challenging in a clinical environment; not only do rabbits tend to hide clinic 
signs of pain, but the lack of a multidimensional composite pain scale can limit assessment of 
their pain and effectiveness of the analgesia provided. The Rabbit Grimace Scale (RbtGS) is a 
valuable tool but may  have a limited use in a veterinary setting where many different rabbit 
breeds are commonly seen.  
Many analgesic drugs used in companion animals such as cats and dogs have not been tested 
on rabbits restricting their use in this species. Many are anecdotally reported, and only few 
analgesic protocols are supported by research studies  that demonstrate a complete pain 
amelioration with the return of normal behaviour of the rabbit.  
Further research should focus on these areas with the aim of improving the welfare of rabbits.  
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